Carregant...
Mining the Genome for Therapeutic Targets
Current pharmacological options for type 2 diabetes do not cure the disease. Despite the availability of multiple drug classes that modulate glycemia effectively and minimize long-term complications, these agents do not reverse pathogenesis, and in practice they are not selected to correct the molec...
Guardat en:
| Publicat a: | Diabetes |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Diabetes Association
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5482091/ https://ncbi.nlm.nih.gov/pubmed/28603140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dbi16-0069 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|